| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
|
PLoS Genet
|
2008
|
6.22
|
|
2
|
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.
|
PLoS Med
|
2010
|
6.04
|
|
3
|
Performance of common genetic variants in breast-cancer risk models.
|
N Engl J Med
|
2010
|
5.79
|
|
4
|
Etiology of hormone receptor-defined breast cancer: a systematic review of the literature.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
5.32
|
|
5
|
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials.
|
Lancet Oncol
|
2015
|
4.84
|
|
6
|
The carcinogenicity of human papillomavirus types reflects viral evolution.
|
Virology
|
2005
|
4.72
|
|
7
|
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
|
J Natl Cancer Inst
|
2010
|
4.54
|
|
8
|
Menopausal hormone replacement therapy and risk of ovarian cancer.
|
JAMA
|
2002
|
4.39
|
|
9
|
Differences in risk factors for breast cancer molecular subtypes in a population-based study.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
4.23
|
|
10
|
Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.
|
J Natl Cancer Inst
|
2010
|
3.95
|
|
11
|
Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine.
|
J Natl Cancer Inst
|
2011
|
3.92
|
|
12
|
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
|
J Infect Dis
|
2005
|
3.84
|
|
13
|
Genome-wide association studies identify four ER negative-specific breast cancer risk loci.
|
Nat Genet
|
2013
|
3.81
|
|
14
|
Comparisons of HPV DNA detection by MY09/11 PCR methods.
|
J Med Virol
|
2002
|
3.53
|
|
15
|
A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.
|
J Infect Dis
|
2005
|
3.46
|
|
16
|
Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease.
|
J Infect Dis
|
2011
|
3.44
|
|
17
|
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.
|
Int J Cancer
|
2009
|
3.15
|
|
18
|
Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study.
|
BMJ
|
2002
|
3.09
|
|
19
|
Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
|
J Natl Cancer Inst
|
2010
|
2.81
|
|
20
|
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.
|
Hum Mol Genet
|
2011
|
2.72
|
|
21
|
Recent trends in breast cancer among younger women in the United States.
|
J Natl Cancer Inst
|
2008
|
2.72
|
|
22
|
Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.
|
BMJ
|
2009
|
2.68
|
|
23
|
Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa Rica.
|
Cancer Discov
|
2011
|
2.66
|
|
24
|
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.
|
Lancet Oncol
|
2013
|
2.48
|
|
25
|
Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.
|
Cancer
|
2004
|
2.46
|
|
26
|
Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality.
|
Cancer Res
|
2006
|
2.33
|
|
27
|
Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.
|
Rev Panam Salud Publica
|
2004
|
2.33
|
|
28
|
Tobacco smoking, NAT2 acetylation genotype and breast cancer risk.
|
Int J Cancer
|
2006
|
2.31
|
|
29
|
CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples.
|
Int J Gynecol Pathol
|
2007
|
2.27
|
|
30
|
Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
2.24
|
|
31
|
Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.
|
Gynecol Oncol
|
2008
|
2.08
|
|
32
|
Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science.
|
Am J Epidemiol
|
2012
|
2.07
|
|
33
|
High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.
|
Int J Cancer
|
2007
|
2.06
|
|
34
|
Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.
|
Gynecol Oncol
|
2013
|
1.89
|
|
35
|
A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
|
J Natl Cancer Inst
|
2002
|
1.83
|
|
36
|
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.
|
Cancer Res
|
2010
|
1.82
|
|
37
|
A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.82
|
|
38
|
19p13.1 is a triple-negative-specific breast cancer susceptibility locus.
|
Cancer Res
|
2012
|
1.81
|
|
39
|
Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium.
|
J Natl Cancer Inst
|
2012
|
1.80
|
|
40
|
A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
1.80
|
|
41
|
Viral load of human papillomavirus and risk of CIN3 or cervical cancer.
|
Lancet
|
2002
|
1.78
|
|
42
|
Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.72
|
|
43
|
Stability of archived liquid-based cervical cytologic specimens.
|
Cancer
|
2003
|
1.70
|
|
44
|
Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.70
|
|
45
|
Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma.
|
Int J Cancer
|
2009
|
1.65
|
|
46
|
Comparison of age distribution patterns for different histopathologic types of breast carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.65
|
|
47
|
Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies.
|
J Infect Dis
|
2002
|
1.58
|
|
48
|
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.56
|
|
49
|
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
|
Hum Mol Genet
|
2011
|
1.56
|
|
50
|
Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages.
|
Menopause
|
2014
|
1.51
|
|
51
|
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study.
|
Breast Cancer Res
|
2010
|
1.51
|
|
52
|
Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study.
|
Gynecol Oncol
|
2010
|
1.47
|
|
53
|
Common genetic variants and risk for HPV persistence and progression to cervical cancer.
|
PLoS One
|
2010
|
1.43
|
|
54
|
Loss of antigenicity in stored sections of breast cancer tissue microarrays.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.43
|
|
55
|
Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia.
|
J Clin Oncol
|
2010
|
1.37
|
|
56
|
A population-based study of vaginal human papillomavirus infection in hysterectomized women.
|
J Infect Dis
|
2004
|
1.36
|
|
57
|
Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer.
|
J Infect Dis
|
2009
|
1.35
|
|
58
|
Detection of genomic amplification of the human telomerase gene (TERC) in cytologic specimens as a genetic test for the diagnosis of cervical dysplasia.
|
Am J Pathol
|
2003
|
1.33
|
|
59
|
Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study.
|
Cancer Causes Control
|
2009
|
1.32
|
|
60
|
Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.32
|
|
61
|
Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study.
|
Int J Cancer
|
2011
|
1.30
|
|
62
|
Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions.
|
Cancer Causes Control
|
2007
|
1.28
|
|
63
|
Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study.
|
BMC Cancer
|
2007
|
1.27
|
|
64
|
11q13 is a susceptibility locus for hormone receptor positive breast cancer.
|
Hum Mutat
|
2012
|
1.26
|
|
65
|
Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
|
Cancer Causes Control
|
2003
|
1.26
|
|
66
|
Assessment of automated image analysis of breast cancer tissue microarrays for epidemiologic studies.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.25
|
|
67
|
Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images.
|
Hum Pathol
|
2004
|
1.25
|
|
68
|
Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
1.23
|
|
69
|
Effects of HIV-1 and herpes simplex virus type 2 infection on lymphocyte and dendritic cell density in adult foreskins from Rakai, Uganda.
|
J Infect Dis
|
2011
|
1.23
|
|
70
|
The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life.
|
Sex Transm Dis
|
2007
|
1.22
|
|
71
|
Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study.
|
Cancer Res
|
2007
|
1.22
|
|
72
|
Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions.
|
J Clin Microbiol
|
2007
|
1.22
|
|
73
|
Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda.
|
AIDS
|
2009
|
1.21
|
|
74
|
Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
|
Breast Cancer Res Treat
|
2009
|
1.20
|
|
75
|
Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.19
|
|
76
|
Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival.
|
J Natl Cancer Inst
|
2010
|
1.17
|
|
77
|
Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers.
|
Breast Cancer Res
|
2012
|
1.16
|
|
78
|
Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers.
|
Toxicol Appl Pharmacol
|
2004
|
1.16
|
|
79
|
Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible.
|
J Clin Microbiol
|
2002
|
1.14
|
|
80
|
Validation of p16INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
1.14
|
|
81
|
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC).
|
PLoS One
|
2012
|
1.13
|
|
82
|
Medication use and risk of ovarian carcinoma: a prospective study.
|
Int J Cancer
|
2004
|
1.13
|
|
83
|
Detection of somatic mutations by high-resolution DNA melting (HRM) analysis in multiple cancers.
|
PLoS One
|
2011
|
1.13
|
|
84
|
Qualitative age interactions in breast cancer studies: mind the gap.
|
J Clin Oncol
|
2009
|
1.12
|
|
85
|
Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study.
|
Am J Epidemiol
|
2012
|
1.10
|
|
86
|
Risk of malignant mixed mullerian tumors after tamoxifen therapy for breast cancer.
|
J Natl Cancer Inst
|
2004
|
1.10
|
|
87
|
A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
1.10
|
|
88
|
Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women.
|
Int J Cancer
|
2006
|
1.09
|
|
89
|
Adulthood lifetime physical activity and breast cancer.
|
Epidemiology
|
2008
|
1.09
|
|
90
|
Direct comparison of HPV16 serological assays used to define HPV-naïve women in HPV vaccine trials.
|
Cancer Epidemiol Biomarkers Prev
|
2012
|
1.09
|
|
91
|
Cytoplasmic estrogen receptor in breast cancer.
|
Clin Cancer Res
|
2011
|
1.07
|
|
92
|
Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
|
Int J Cancer
|
2012
|
1.07
|
|
93
|
Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes.
|
Carcinogenesis
|
2010
|
1.07
|
|
94
|
Correlates of IL-10 and IL-12 concentrations in cervical secretions.
|
J Clin Immunol
|
2003
|
1.06
|
|
95
|
Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.
|
J Clin Microbiol
|
2003
|
1.05
|
|
96
|
PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma.
|
Cancer Res
|
2008
|
1.05
|
|
97
|
Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998.
|
Cancer
|
2002
|
1.04
|
|
98
|
DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.04
|
|
99
|
Determinants of seropositivity among HPV-16/18 DNA positive young women.
|
BMC Infect Dis
|
2010
|
1.03
|
|
100
|
Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.
|
Int J Cancer
|
2012
|
1.03
|
|
101
|
Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.
|
Cancer
|
2002
|
1.03
|
|
102
|
Postpartum remodeling, lactation, and breast cancer risk: summary of a National Cancer Institute-sponsored workshop.
|
J Natl Cancer Inst
|
2012
|
1.02
|
|
103
|
Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas.
|
Am J Surg Pathol
|
2002
|
1.02
|
|
104
|
Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
|
Sex Transm Dis
|
2010
|
1.02
|
|
105
|
Cervical tissue collection methods for RNA preservation: comparison of snap-frozen, ethanol-fixed, and RNAlater-fixation.
|
Diagn Mol Pathol
|
2006
|
1.02
|
|
106
|
Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom.
|
Cancer
|
2002
|
1.01
|
|
107
|
Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens.
|
J Clin Microbiol
|
2012
|
0.99
|
|
108
|
Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
|
Cancer
|
2008
|
0.98
|
|
109
|
Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning.
|
Cancer Res
|
2008
|
0.98
|
|
110
|
Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States.
|
J Clin Oncol
|
2013
|
0.97
|
|
111
|
Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.97
|
|
112
|
Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal women.
|
Int J Cancer
|
2004
|
0.96
|
|
113
|
Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivity.
|
Sex Transm Dis
|
2002
|
0.95
|
|
114
|
Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression.
|
Breast Cancer Res Treat
|
2013
|
0.95
|
|
115
|
Evaluation of candidate methylation markers to detect cervical neoplasia.
|
Gynecol Oncol
|
2007
|
0.94
|
|
116
|
Proceedings of the second international molecular pathological epidemiology (MPE) meeting.
|
Cancer Causes Control
|
2015
|
0.94
|
|
117
|
Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer.
|
PLoS One
|
2012
|
0.93
|
|
118
|
Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infections.
|
Hum Pathol
|
2008
|
0.93
|
|
119
|
Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.
|
Pharmacogenet Genomics
|
2006
|
0.93
|
|
120
|
Clinical and pathological heterogeneity of cervical intraepithelial neoplasia grade 3.
|
PLoS One
|
2012
|
0.93
|
|
121
|
Can cervicography be improved? An evaluation with arbitrated cervicography interpretations.
|
Am J Obstet Gynecol
|
2002
|
0.93
|
|
122
|
Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women.
|
Breast Cancer Res Treat
|
2011
|
0.92
|
|
123
|
Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.
|
Gynecol Oncol
|
2010
|
0.92
|
|
124
|
Weight, height, and body mass index and risk for ovarian cancer in a cohort study.
|
Ann Epidemiol
|
2006
|
0.92
|
|
125
|
Absolute risk models for subtypes of breast cancer.
|
J Natl Cancer Inst
|
2007
|
0.91
|
|
126
|
Recent changes in endometrial cancer trends among menopausal-age U.S. women.
|
Cancer Epidemiol
|
2013
|
0.91
|
|
127
|
Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure.
|
Sex Transm Dis
|
2011
|
0.91
|
|
128
|
Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
0.91
|
|
129
|
Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.
|
Cancer Causes Control
|
2012
|
0.91
|
|
130
|
Atypical glandular cells of undetermined significance (AGUS): Interobserver reproducibility in cervical smears and corresponding thin-layer preparations.
|
Am J Clin Pathol
|
2002
|
0.91
|
|
131
|
Accuracy of cervical specimens obtained for biomarker studies in women with CIN3.
|
Gynecol Oncol
|
2009
|
0.91
|
|
132
|
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors.
|
Int J Cancer
|
2014
|
0.90
|
|
133
|
Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma.
|
Diagn Mol Pathol
|
2006
|
0.90
|
|
134
|
Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer.
|
Int J Cancer
|
2009
|
0.90
|
|
135
|
Relationships of uterine and ovarian tumors to pre-existing chronic conditions.
|
Gynecol Oncol
|
2007
|
0.89
|
|
136
|
Intrauterine environment and breast cancer risk in a population-based case-control study in Poland.
|
Int J Cancer
|
2006
|
0.89
|
|
137
|
Measurement of sex steroid hormones in breast adipocytes: methods and implications.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.88
|
|
138
|
Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study.
|
Gynecol Oncol
|
2006
|
0.87
|
|
139
|
Active and passive cigarette smoking and the risk of endometrial cancer in Poland.
|
Eur J Cancer
|
2009
|
0.87
|
|
140
|
Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository.
|
Cancer Causes Control
|
2013
|
0.87
|
|
141
|
Discovery and validation of methylation markers for endometrial cancer.
|
Int J Cancer
|
2014
|
0.86
|
|
142
|
Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.
|
Int J Cancer
|
2011
|
0.85
|
|
143
|
Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study.
|
J Clin Endocrinol Metab
|
2012
|
0.85
|
|
144
|
Parity-related molecular signatures and breast cancer subtypes by estrogen receptor status.
|
Breast Cancer Res
|
2014
|
0.84
|
|
145
|
Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland.
|
Breast Cancer Res
|
2011
|
0.83
|
|
146
|
Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan.
|
Int J Cancer
|
2012
|
0.82
|
|
147
|
Effect of different human papillomavirus serological and DNA criteria on vaccine efficacy estimates.
|
Am J Epidemiol
|
2014
|
0.82
|
|
148
|
Reproducibility of linear array for human papillomavirus genotyping.
|
J Clin Microbiol
|
2012
|
0.82
|
|
149
|
Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.
|
Int J Cancer
|
2014
|
0.82
|
|
150
|
Towards improved biomarker studies of cervical neoplasia: effects of precolposcopic procedures on gene expression patterns.
|
Diagn Mol Pathol
|
2005
|
0.81
|
|
151
|
Estrogen receptor and progesterone receptor expression in normal terminal duct lobular units surrounding invasive breast cancer.
|
Breast Cancer Res Treat
|
2012
|
0.81
|
|
152
|
Association of serum sex steroid hormone hemodilution and body mass index among healthy postmenopausal women.
|
Ann Epidemiol
|
2011
|
0.80
|
|
153
|
7q21-rs6964587 and breast cancer risk: an extended case-control study by the Breast Cancer Association Consortium.
|
J Med Genet
|
2011
|
0.80
|
|
154
|
Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
0.80
|
|
155
|
Salpingitis, salpingoliths, and serous tumors of the ovaries: is there a connection?
|
Int J Gynecol Pathol
|
2002
|
0.80
|
|
156
|
Alcohol and endometrial cancer risk in the NIH-AARP diet and health study.
|
Int J Cancer
|
2010
|
0.79
|
|
157
|
Ogino et Al. Respond to "the 21st century epidemiologist".
|
Am J Epidemiol
|
2012
|
0.79
|
|
158
|
Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.
|
Int J Cancer
|
2011
|
0.78
|
|
159
|
Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal women.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.78
|
|
160
|
Greater absolute risk for all subtypes of breast cancer in the US than Malaysia.
|
Breast Cancer Res Treat
|
2014
|
0.77
|
|
161
|
Association of TGF-β2 levels in breast milk with severity of breast biopsy diagnosis.
|
Cancer Causes Control
|
2015
|
0.77
|
|
162
|
Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland.
|
Horm Cancer
|
2013
|
0.77
|
|
163
|
Relationship of serum estrogens and metabolites with area and volume mammographic densities.
|
Horm Cancer
|
2015
|
0.77
|
|
164
|
Lobular involution, mammographic density, and breast cancer risk: visualizing the future?
|
J Natl Cancer Inst
|
2010
|
0.77
|
|
165
|
Human papillomavirus vaccines for cervical cancer prevention: translating possibility into reality.
|
J Natl Cancer Inst
|
2012
|
0.76
|
|
166
|
Endometrial thickness and risk of breast and endometrial carcinomas in the prostate, lung, colorectal and ovarian cancer screening trial.
|
Int J Cancer
|
2013
|
0.76
|
|
167
|
Right-sided ectocervical lesions may be associated with false-negative cytology among women with histologic cervical intraepithelial neoplasia 2 or 3.
|
J Low Genit Tract Dis
|
2003
|
0.76
|
|
168
|
Learning from disease heterogeneity.
|
Lancet Oncol
|
2012
|
0.76
|
|
169
|
Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States.
|
Int J Cancer
|
2005
|
0.76
|
|
170
|
Clarifying breast cancer risks associated with menopausal hormone therapy.
|
Lancet Oncol
|
2006
|
0.76
|
|
171
|
From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination.
|
J Natl Cancer Inst
|
2013
|
0.75
|
|
172
|
The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology: Toward Strengthening the Critical Relationship.
|
Am J Surg Pathol
|
2016
|
0.75
|
|
173
|
Breast cancer risk in older women: results from the NIH-AARP Diet and Health Study.
|
Cancer Causes Control
|
2014
|
0.75
|
|
174
|
Beyond breast cancer: mammographic features and mortality risk in a population of healthy women.
|
PLoS One
|
2013
|
0.75
|
|
175
|
Epidemiologic risk factors for in situ and invasive breast cancer among postmenopausal women in the NIH-AARP Diet and Health Study.
|
Am J Epidemiol
|
2017
|
0.75
|